Keith R. Gollust and David Milligan resigned from the Board of Directors of Madrigal Pharmaceuticals, Inc., while Julian Baker and Raymond Cheong were appointed as new directors. The Chairman and Chief Executive Officer functions were separated, with Julian Baker appointed as the independent Chairman of the Board of Directors.